Pharmapedia Pro
Medicines/Generics/Flunarizine (HCl)

Flunarizine (HCl)

Generic medicine reference

Not yet clinically reviewed

This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.

Spot an error in this entry? Submit a correction
Overview
Flunarizine (HCl) is a sedating antihistamine and difluorinated derivative of cinnarizine. Flunarizine (HCl) is investigational calcium channel blocker. It has been reported in preliminary trials to effectively reduce the severity of the acute attack of migraine and prevent recurrences.
Indications
Flunarizine (HCl) is primarily indicated in conditions like Dizziness, Migraine prophylaxis, Tinnitus, Vertigo.
Contraindications
Flunarizine (HCl) is contraindicated in conditions like Depressive illness, Symptomatic parkinsonism, Hypersensitivity to the drug.
Side Effects
Flunarizine (HCl) produces potentially life-threatening effects which include Tremor, Rigidity, Orofacial dyskinesia, Bradykinesia. which are responsible for the discontinuation of Flunarizine (HCl) therapy. The symptomatic adverse reactions produced by Flunarizine (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Drowsiness, Nausea, Vomiting, Diarrhea, Dry mouth, Asthenia, Heart burn, Skin rashes, Myalgia, Increased appetite, Depression.
Warnings
Patients should observed caution while driving or performing other tasks requiring alertness, because may cause drowsiness. Flunarizine should be used with caution in patients with liver impairment, dose should be reduced in patients with renal impairment. Avoid use in young children and use with caution in elderly patients.
High Risk Groups
Drug should not be given to Pregnant Mothers. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
5 mg (5 (5)) 12 hourly PO —
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Flunarizine (HCl) was found.
Storage
No storage information is recorded for this medicine yet.

Available Brands in Pakistan

2 active brands listed alphabetically.

MIGRAM

Active

AMARANT PHARMACEUTICALS (PVT)

DML: MIGRAM

Caps

SIBELIUM

Active

JANSSEN-CILAG

DML: SIBELIUM

Caps

2 additional records are present but flagged "Unverified / Legacy" and not listed.